ArticleAnnals of the rheumatic diseases2024

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials.

Matthew A Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.